glp-1/gip dual agonist lilly GLP-1 use tripled among non-diabetics, reaching $5.8B in 2022 FDA approves tirzepatide, Eli Lilly's
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12





















